Acquired Hemophilia: Successfully Treated with Plasma Exchange in a Patient with Hightiter Inhibitors / 대한수혈학회지
Korean Journal of Blood Transfusion
;
: 68-71, 2012.
Article
in Korean
| WPRIM
| ID: wpr-76692
ABSTRACT
Acquired hemophilia is an extremely rare but life threatening hemorrhagic disease caused by autoantibodies directed coagulation factor VIII. Estimated management guidelines include rapid diagnosis, suppression of bleeding, and elimination of inhibitors by use of immunosuppressants. Plasma exchange is used restrictively as an adjuvant in order to lower the level of inhibitor. We report on a successful therapeutic experience with plasma exchange in a patient with refractory acquired hemophilia. After performance of the plasma exchange procedure, bleeding was controlled and results of coagulation tests showed improvement according to the decrease in levels of factor VIII inhibitor.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Plasma
/
Plasma Exchange
/
Autoantibodies
/
Factor VIII
/
Hemophilia A
/
Hemorrhage
/
Immunosuppressive Agents
Type of study:
Practice guideline
Limits:
Humans
Language:
Korean
Journal:
Korean Journal of Blood Transfusion
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS